PC
ADPT icon

Pier Capital’s Adaptive Biotechnologies ADPT Stock Holding History

Pier Capital’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-234,848
Closed -$3.81M – 124
2025
Q4 		$3.81M Sell
234,848
-400,235
-63% -$6.53M 0.61% 79
2025
Q3 		$9.5M Sell
635,083
-381,803
-38% -$4.65M 1.49% 12
2025
Q2 		$11.8M Sell
1,016,886
-80,501
-7% -$731K 1.81% 5
2025
Q1 		$8.15M Sell
1,097,387
-176,906
-14% -$1.36M 1.37% 26
2024
Q4 		$7.64M Sell
1,274,293
-1,592
-0.1% -$8.78K 1.09% 51
2024
Q3 		$6.53M Buy
1,275,885
+220,586
+21% +$961K 0.92% 60
2024
Q2 		$3.82M Sell
1,055,299
-48,142
-4% -$153K 0.57% 87
2024
Q1 		$3.54M Buy
1,103,441
+392,334
+55% +$1.52M 0.49% 88
2023
Q4 		$3.48M Sell
711,107
-7,960
-1% -$36.3K 0.5% 89
2023
Q3 		$3.92M Sell
719,067
-18,522
-3% -$122K 0.63% 78
2023
Q2 		$4.95M Sell
737,589
-86,397
-10% -$642K 0.71% 73
2023
Q1 		$7.28M Sell
823,986
-188,415
-19% -$1.66M 1.1% 46
2022
Q4 		$7.73M Buy
1,012,401
+184,099
+22% +$1.43M 1.27% 31
2022
Q3 		$5.9M Buy
828,302
+489,513
+144% +$4.61M 1.01% 56
2022
Q2 		$2.74M Sell
338,789
-752
-0.2% -$6.61K 0.47% 86
2022
Q1 		$4.71M Buy
339,541
+143,239
+73% +$2.25M 0.6% 81
2021
Q4 		$5.51M Sell
196,302
-1,190
-0.6% -$36.5K 0.58% 86
2021
Q3 		$6.71M Sell
197,492
-2,205
-1% -$79.7K 0.7% 80
2021
Q2 		$8.16M Buy
199,697
+42,736
+27% +$1.66M 0.82% 77
2021
Q1 		$6.32M Buy
156,961
+9,993
+7% +$541K 0.6% 86
2020
Q4 		$8.69M Buy
146,968
+5,606
+4% +$289K 0.92% 71
2020
Q3 		$6.87M Buy
141,362
+25,333
+22% +$1.06M 1% 60
2020
Q2 		$5.61M Buy
+116,029
New +$4.23M 0.9% 66

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Pier Capital's ADPT Position: Q1 2026 in Review

Pier Capital sold out of Adaptive Biotechnologies (ADPT) in Q1 2026, closing a stake of 234,848 shares — an estimated $3.81M sold.

Pier Capital first reported a position in ADPT in Q2 2020 and held it in 23 quarters. The position peaked at $11.8M in Q2 2025. 298 funds tracked by Wall St. Rank hold ADPT as of Q1 2026.

  • Pier Capital reported no remaining Adaptive Biotechnologies position as of Q1 2026 after selling out during the quarter.
  • Pier Capital sold 234,848 Adaptive Biotechnologies shares in Q1 2026, an estimated $3.81M.
  • Pier Capital first reported a position in Adaptive Biotechnologies in Q2 2020 and held it in 23 quarters.
  • Pier Capital's Adaptive Biotechnologies position peaked at $11.8M in Q2 2025.
  • 298 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2026.

Based on Pier Capital's 13F filing for Q1 2026, filed 14 May 2026.